147 related articles for article (PubMed ID: 35273097)
1. MAdCAM-1 Costimulates T Cells through Integrin α
DeBerg HA; Konecny AJ; Shows DM; Lord JD
Immunohorizons; 2022 Mar; 6(3):211-223. PubMed ID: 35273097
[TBL] [Abstract][Full Text] [Related]
2. MAdCAM costimulation through Integrin-α
Nawaz F; Goes LR; Ray JC; Olowojesiku R; Sajani A; Ansari AA; Perrone I; Hiatt J; Van Ryk D; Wei D; Waliszewski M; Soares MA; Jelicic K; Connors M; Migueles SA; Martinelli E; Villinger F; Cicala C; Fauci AS; Arthos J
Mucosal Immunol; 2018 Sep; 11(5):1342-1351. PubMed ID: 29875402
[TBL] [Abstract][Full Text] [Related]
3. Blocking integrin α
Rai RP; Liu Y; Iyer SS; Liu S; Gupta B; Desai C; Kumar P; Smith T; Singhi AD; Nusrat A; Parkos CA; Monga SP; Czaja MJ; Anania FA; Raeman R
J Hepatol; 2020 Nov; 73(5):1013-1022. PubMed ID: 32540177
[TBL] [Abstract][Full Text] [Related]
4. Vedolizumab Antagonizes MAdCAM-1-Dependent Human Placental Cytotrophoblast Adhesion and Invasion In Vitro.
Blaisdell A; Zhou Y; Kattah MG; Fisher SJ; Mahadevan U
Inflamm Bowel Dis; 2022 Aug; 28(8):1219-1228. PubMed ID: 35349682
[TBL] [Abstract][Full Text] [Related]
5. The V2 loop of HIV gp120 delivers costimulatory signals to CD4
Goes LR; Sajani A; Sivro A; Olowojesiku R; Ray JC; Perrone I; Yolitz J; Girard A; Leyre L; Wibmer CK; Morris L; Gorini G; Franchini G; Mason RD; Roederer M; Mehandru S; Soares MA; Cicala C; Fauci AS; Arthos J
Proc Natl Acad Sci U S A; 2020 Dec; 117(51):32566-32573. PubMed ID: 33288704
[TBL] [Abstract][Full Text] [Related]
6. α4β7 integrin-dependent adhesion of T cells to MAdCAM-1 is blocked by vedolizumab in patients with chronic refractory pouchitis.
Melde M; Müller TM; Schneider I; Geppert CI; Mühl L; Besendorf L; Allner C; Becker E; Atreya I; Vitali F; Atreya R; Neurath MF; Zundler S
Therap Adv Gastroenterol; 2021; 14():17562848211054707. PubMed ID: 34868349
[TBL] [Abstract][Full Text] [Related]
7. MAdCAM-1 costimulates T cell proliferation exclusively through integrin alpha4beta7, whereas VCAM-1 and CS-1 peptide use alpha4beta1: evidence for "remote" costimulation and induction of hyperresponsiveness to B7 molecules.
Lehnert K; Print CG; Yang Y; Krissansen GW
Eur J Immunol; 1998 Nov; 28(11):3605-15. PubMed ID: 9842903
[TBL] [Abstract][Full Text] [Related]
8. Vedolizumab blocks α4β7 integrin-mediated T cell adhesion to MAdCAM-1 in microscopic colitis.
Besendorf L; Müller TM; Geppert CI; Schneider I; Mühl L; Atreya I; Vitali F; Atreya R; Neurath MF; Zundler S
Therap Adv Gastroenterol; 2022; 15():17562848221098899. PubMed ID: 35784193
[TBL] [Abstract][Full Text] [Related]
9. Lymphocyte binding to MAdCAM-1 via alpha4beta7 integrin activates a signal transduction pathway involving tyrosine phosphorylation of paxillin and p105(Cas-L).
Murata S; Tanaka T; Miyasaka M
Immunol Lett; 2002 May; 81(3):223-8. PubMed ID: 11947929
[TBL] [Abstract][Full Text] [Related]
10. The binding specificity and selective antagonism of vedolizumab, an anti-alpha4beta7 integrin therapeutic antibody in development for inflammatory bowel diseases.
Soler D; Chapman T; Yang LL; Wyant T; Egan R; Fedyk ER
J Pharmacol Exp Ther; 2009 Sep; 330(3):864-75. PubMed ID: 19509315
[TBL] [Abstract][Full Text] [Related]
11. Circulating exosomes express α4β7 integrin and compete with CD4+ T cells for the binding to Vedolizumab.
Domenis R; Marino M; Cifù A; Scardino G; Curcio F; Fabris M
PLoS One; 2020; 15(11):e0242342. PubMed ID: 33180848
[TBL] [Abstract][Full Text] [Related]
12. Selective Targeting of α
Gupta B; Rai RP; Pal PB; Rossmiller D; Chaudhary S; Chiaro A; Seaman S; Singhi AD; Liu S; Monga SP; Iyer SS; Raeman R
Cells; 2024 Apr; 13(9):. PubMed ID: 38727292
[TBL] [Abstract][Full Text] [Related]
13. Regulation and Role of αE Integrin and Gut Homing Integrins in Migration and Retention of Intestinal Lymphocytes during Inflammatory Bowel Disease.
Keir ME; Fuh F; Ichikawa R; Acres M; Hackney JA; Hulme G; Carey CD; Palmer J; Jones CJ; Long AK; Jiang J; Klabunde S; Mansfield JC; Looney CM; Faubion WA; Filby A; Kirby JA; McBride J; Lamb CA
J Immunol; 2021 Nov; 207(9):2245-2254. PubMed ID: 34561227
[TBL] [Abstract][Full Text] [Related]
14. TET inducible expression of the α4β7-integrin ligand MAdCAM-1 on the blood-brain barrier does not influence the immunopathogenesis of experimental autoimmune encephalomyelitis.
Döring A; Pfeiffer F; Meier M; Dehouck B; Tauber S; Deutsch U; Engelhardt B
Eur J Immunol; 2011 Mar; 41(3):813-21. PubMed ID: 21341265
[TBL] [Abstract][Full Text] [Related]
15. Expression of MAdCAM-1 and Gut-homing T Cells in Inflamed Pouch Mucosa.
de Krijger M; Wildenberg ME; Mookhoek A; Verheul S; de Jonge WJ; Ponsioen CY
J Crohns Colitis; 2021 Sep; 15(9):1491-1499. PubMed ID: 33675360
[TBL] [Abstract][Full Text] [Related]
16. The Force-Dependent Mechanism of an Integrin α4β7-MAdCAM-1 Interaction.
Su Y; Luo Z; Sun D; Yang B; Li Q
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003252
[TBL] [Abstract][Full Text] [Related]
17. Baseline levels of dynamic CD4
Allner C; Melde M; Becker E; Fuchs F; Mühl L; Klenske E; Müller L; Morgenstern N; Fietkau K; Hirschmann S; Atreya R; Atreya I; Neurath MF; Zundler S
BMC Gastroenterol; 2020 Apr; 20(1):103. PubMed ID: 32293299
[TBL] [Abstract][Full Text] [Related]
18. The Role of Integrin α
Kasarpalkar N; Deb B; Kumar P; Bhor VM
OMICS; 2020 Jul; 24(7):437-450. PubMed ID: 32522079
[TBL] [Abstract][Full Text] [Related]
19. Gut-Selective Integrin-Targeted Therapies for Inflammatory Bowel Disease.
Lamb CA; O'Byrne S; Keir ME; Butcher EC
J Crohns Colitis; 2018 Aug; 12(suppl_2):S653-S668. PubMed ID: 29767705
[TBL] [Abstract][Full Text] [Related]
20. Similar Inhibition of Dynamic Adhesion of Lymphocytes From IBD Patients to MAdCAM-1 by Vedolizumab and Etrolizumab-s.
Binder MT; Becker E; Wiendl M; Schleier L; Fuchs F; Leppkes M; Atreya R; Neufert C; Atreya I; Neurath MF; Zundler S
Inflamm Bowel Dis; 2018 May; 24(6):1237-1250. PubMed ID: 29788362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
